Clinical features in toxic coma in children

Simona Stanca1, Coriolan Emil Ulmeanu2, Horia Tudor Stanca3

  • 1Department of Pediatrics, 'Carol Davila' University of Medicine and Pharmacy, 'Grigore Alexandrescu' Clinical Emergency Hospital for Children, 050474 Bucharest, Romania.

Insights

Toxicants are the primary cause of coma in children, with alcohol and substances being most common. Early recognition of clinical signs is crucial for managing toxic coma severity and complications.

Area of Science:

  • Pediatric Emergency Medicine
  • Toxicology
  • Neurology

Background:

  • Toxic coma is a critical medical emergency in children.
  • Rapid evaluation and precise diagnosis are essential for effective management.
  • Identifying etiological factors and severity is paramount.

Purpose of the Study:

  • To rapidly identify the causes of toxic coma in children.
  • To assess coma severity and associated clinical indicators.
  • To evaluate initial treatment strategies for toxic coma.

Main Methods:

  • Retrospective analysis of 750 comatose patients (2003-2011).
  • Focus on toxic coma etiology, clinical signs, and severity.
  • Inclusion of a prospective component for early diagnosis and therapy initiation.

Main Results:

  • Toxicants caused 59.3% of pediatric coma cases (445 patients).
  • Alcohol and substance abuse were the leading causes of toxic coma.
  • Coma severity correlated with increased frequency and severity of clinical manifestations.

Conclusions:

  • Toxicants are the predominant cause of coma in pediatric emergency settings.
  • Clinical manifestations aid in recognizing severity and associated complications like aspiration, arrhythmias, and seizures.
  • Prompt evaluation and management are critical for improving outcomes in pediatric toxic coma.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
155
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
200
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
688